Terence Friedlander
Medical oncologist who moderates the session and guides discussions on novel approaches to non‑muscle invasive and muscle‑invasive bladder cancer; served as the meeting moderator for this episode.
Best podcasts with Terence Friedlander
Ranked by the Snipd community
Feb 23, 2026 • 23min
Urothelial Bladder Cancer — Microlearning Activity 2 with Dr Terence Friedlander: ESMO Congress 2025 Review
Dr Terence Friedlander, UCSF medical oncologist and bladder cancer investigator, discusses selection and sequencing of therapies and highlights key ESMO 2025 findings. He covers NIAGARA perioperative results, ADCs targeting HER2 and Trop-2, cross-resistance and payload concerns, T-DXd activity and ILD risk, and practical sequencing for frail or chemo-ineligible patients.
